These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 6696043)
1. Pathologic changes in murine leishmaniasis (Leishmania donovani) with special reference to the dynamics of granuloma formation in the liver. Gutierrez Y; Maksem JA; Reiner NE Am J Pathol; 1984 Feb; 114(2):222-30. PubMed ID: 6696043 [TBL] [Abstract][Full Text] [Related]
2. Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study. Salguero FJ; Garcia-Jimenez WL; Lima I; Seifert K Parasit Vectors; 2018 Jan; 11(1):73. PubMed ID: 29386047 [TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani: clinical, hematologic and hepatic changes in squirrel monkeys (Saimiri sciureus). Dennis VA; Chapman WL; Hanson WL; Lujan R J Parasitol; 1985 Oct; 71(5):576-82. PubMed ID: 4057001 [TBL] [Abstract][Full Text] [Related]
4. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421 [TBL] [Abstract][Full Text] [Related]
5. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. Squires KE; Schreiber RD; McElrath MJ; Rubin BY; Anderson SL; Murray HW J Immunol; 1989 Dec; 143(12):4244-9. PubMed ID: 2512353 [TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide affects the dynamics of granuloma formation in experimental visceral leishmaniasis. Corrêa EB; Cunha JM; Bunn-Moreno MM; Madeira ED Parasitol Res; 1992; 78(2):154-60. PubMed ID: 1557327 [TBL] [Abstract][Full Text] [Related]
7. Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection. Robert-Gangneux F; Drogoul AS; Rostan O; Piquet-Pellorce C; Cayon J; Lisbonne M; Herbelin A; Gascan H; Guiguen C; Samson M; Gangneux JP PLoS One; 2012; 7(3):e33413. PubMed ID: 22457760 [TBL] [Abstract][Full Text] [Related]
8. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. Murray HW; Squires KE; Miralles CD; Stoeckle MY; Granger AM; Granelli-Piperno A; Bogdan C J Immunol; 1992 Mar; 148(6):1858-63. PubMed ID: 1541824 [TBL] [Abstract][Full Text] [Related]
9. The pathology of experimental visceral leishmaniasis in resistant and susceptible lines of inbred mice. Barbosa Júnior AA; Andrade ZA; Reed SG Braz J Med Biol Res; 1987; 20(1):63-72. PubMed ID: 3690047 [TBL] [Abstract][Full Text] [Related]
10. Histopathological studies of Syrian golden hamsters experimentally infected with Leishmania D. infantum. Mangoud AM; Ramadan ME; Morsy TA; Amin AM; Mostafa SM J Egypt Soc Parasitol; 1997 Dec; 27(3):689-702. PubMed ID: 9425815 [TBL] [Abstract][Full Text] [Related]
12. B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis. Moore JW; Beattie L; Dalton JE; Owens BM; Maroof A; Coles MC; Kaye PM PLoS One; 2012; 7(3):e34143. PubMed ID: 22479545 [TBL] [Abstract][Full Text] [Related]
13. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456 [TBL] [Abstract][Full Text] [Related]
14. [Experimental visceral leishmaniasis in golden hamsters]. Shukina EE; Gorbunova LA Parazitologiia; 1987; 21(5):637-42. PubMed ID: 3431905 [TBL] [Abstract][Full Text] [Related]
15. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected. Abreu-Silva AL; Calabrese KS; Cupolilo SM; Cardoso FO; Souza CS; Gonçalves da Costa SC Vet Parasitol; 2004 May; 121(3-4):179-87. PubMed ID: 15135858 [TBL] [Abstract][Full Text] [Related]
16. Effector role of blood monocytes in experimental visceral leishmaniasis. Cervia JS; Rosen H; Murray HW Infect Immun; 1993 Apr; 61(4):1330-3. PubMed ID: 8454335 [TBL] [Abstract][Full Text] [Related]
17. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani. Barbi J; Oghumu S; Rosas LE; Carlson T; Lu B; Gerard C; Lezama-Davila CM; Satoskar AR J Infect Dis; 2007 Jun; 195(11):1713-7. PubMed ID: 17471442 [TBL] [Abstract][Full Text] [Related]
18. Immunohistological features of visceral leishmaniasis in BALB/c mice. Carrión J; Nieto A; Iborra S; Iniesta V; Soto M; Folgueira C; Abanades DR; Requena JM; Alonso C Parasite Immunol; 2006 May; 28(5):173-83. PubMed ID: 16629702 [TBL] [Abstract][Full Text] [Related]
19. Experimental visceral leishmaniasis in the owl monkey. Broderson JR; Chapman WL; Hanson WL Vet Pathol; 1986 May; 23(3):293-302. PubMed ID: 3727315 [TBL] [Abstract][Full Text] [Related]
20. Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Stäger S; Alexander J; Carter KC; Brombacher F; Kaye PM Infect Immun; 2003 Aug; 71(8):4804-7. PubMed ID: 12874364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]